WORLDWIDE‑CORRUPTION

China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)

地塞米松磷酸钠原料药经营者

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (津市监垄处〔2025〕1号; 津市监垄处〔2025〕2号; 津市监垄处〔2025〕3号; 津市监垄处〔2025〕4号; 津市监垄处〔2025〕5号 · 市场监管总局发布地塞米松磷酸钠原料药垄断协议案行政处罚决定书), from 13 June 2025.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).

Details

Company
地塞米松磷酸钠原料药经营者
Authority
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
Decision
Cartel (monopoly agreement)
Grounds and details, as published
津市监垄处〔2025〕1号; 津市监垄处〔2025〕2号; 津市监垄处〔2025〕3号; 津市监垄处〔2025〕4号; 津市监垄处〔2025〕5号 · 市场监管总局发布地塞米松磷酸钠原料药垄断协议案行政处罚决定书
From
13 June 2025
Until
—
Status
End date not published
Source
https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2025/art_52d5d88552ce44d8adab6f1ca11a5455.html
Licence
Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)

SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)